Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endometrial Neoplasms | 51 | 2023 | 1353 | 5.830 |
Why?
|
Endometrium | 25 | 2023 | 424 | 3.970 |
Why?
|
Precancerous Conditions | 30 | 2020 | 975 | 3.760 |
Why?
|
Endometrial Hyperplasia | 18 | 2023 | 97 | 3.570 |
Why?
|
Carcinoma in Situ | 16 | 2020 | 806 | 2.460 |
Why?
|
Morphogenesis | 3 | 2018 | 752 | 1.470 |
Why?
|
Carcinoma, Endometrioid | 8 | 2019 | 271 | 1.460 |
Why?
|
Phosphoric Monoester Hydrolases | 12 | 2005 | 431 | 1.130 |
Why?
|
PTEN Phosphohydrolase | 20 | 2023 | 1142 | 1.050 |
Why?
|
Uterine Neoplasms | 11 | 2019 | 1513 | 0.940 |
Why?
|
PAX2 Transcription Factor | 4 | 2012 | 80 | 0.910 |
Why?
|
Embryonic Development | 2 | 2018 | 711 | 0.900 |
Why?
|
Receptors, Progesterone | 8 | 2023 | 1097 | 0.870 |
Why?
|
Progesterone | 3 | 2015 | 776 | 0.840 |
Why?
|
Computational Biology | 4 | 2018 | 3521 | 0.840 |
Why?
|
Tumor Suppressor Proteins | 13 | 2005 | 2849 | 0.710 |
Why?
|
Leiomyoma | 4 | 2015 | 730 | 0.660 |
Why?
|
Embryology | 1 | 2018 | 29 | 0.640 |
Why?
|
Genes, Tumor Suppressor | 10 | 2010 | 1097 | 0.610 |
Why?
|
Uterine Diseases | 5 | 2004 | 135 | 0.570 |
Why?
|
Intrauterine Devices | 2 | 2009 | 122 | 0.550 |
Why?
|
Immunohistochemistry | 21 | 2020 | 11366 | 0.550 |
Why?
|
Cell Transformation, Neoplastic | 8 | 2010 | 2942 | 0.510 |
Why?
|
Cystadenocarcinoma, Serous | 5 | 2010 | 450 | 0.510 |
Why?
|
Progestins | 3 | 2006 | 306 | 0.510 |
Why?
|
Microsatellite Repeats | 12 | 2007 | 802 | 0.490 |
Why?
|
Polymerase Chain Reaction | 19 | 2010 | 6171 | 0.480 |
Why?
|
Adenocarcinoma | 8 | 2012 | 6364 | 0.440 |
Why?
|
Leiomyosarcoma | 2 | 2015 | 477 | 0.420 |
Why?
|
Dosage Compensation, Genetic | 4 | 1997 | 211 | 0.410 |
Why?
|
Spermatozoa | 5 | 2016 | 625 | 0.400 |
Why?
|
Myometrium | 3 | 2008 | 181 | 0.380 |
Why?
|
Biopsy | 13 | 2014 | 6756 | 0.380 |
Why?
|
Algorithms | 2 | 2020 | 13881 | 0.360 |
Why?
|
DNA, Neoplasm | 11 | 2007 | 1758 | 0.350 |
Why?
|
Norpregnadienes | 1 | 2009 | 3 | 0.350 |
Why?
|
Hysterectomy | 7 | 2012 | 927 | 0.330 |
Why?
|
Hormone Antagonists | 1 | 2008 | 108 | 0.310 |
Why?
|
Polyps | 2 | 2009 | 189 | 0.310 |
Why?
|
Female | 101 | 2023 | 380194 | 0.300 |
Why?
|
Teratoma | 5 | 1997 | 395 | 0.290 |
Why?
|
Menstrual Cycle | 4 | 2015 | 551 | 0.290 |
Why?
|
Contraceptives, Oral | 1 | 2009 | 564 | 0.280 |
Why?
|
Carcinoma | 7 | 2019 | 2375 | 0.270 |
Why?
|
Uterus | 5 | 2019 | 711 | 0.260 |
Why?
|
Genomic Imprinting | 2 | 1997 | 328 | 0.260 |
Why?
|
Vulvar Neoplasms | 7 | 2003 | 272 | 0.260 |
Why?
|
Hydatidiform Mole | 5 | 2003 | 279 | 0.260 |
Why?
|
X Chromosome | 6 | 1997 | 814 | 0.250 |
Why?
|
Reproductive Techniques | 2 | 2016 | 42 | 0.250 |
Why?
|
Endometriosis | 3 | 2014 | 839 | 0.250 |
Why?
|
Computer Simulation | 1 | 2018 | 6196 | 0.250 |
Why?
|
Epithelial Cells | 7 | 2020 | 3690 | 0.240 |
Why?
|
Tissue Preservation | 1 | 2004 | 182 | 0.240 |
Why?
|
Freezing | 1 | 2004 | 303 | 0.240 |
Why?
|
Humans | 117 | 2023 | 744343 | 0.240 |
Why?
|
Tumor Suppressor Protein p53 | 6 | 2010 | 2948 | 0.230 |
Why?
|
Loss of Heterozygosity | 9 | 2007 | 684 | 0.230 |
Why?
|
Fallopian Tube Neoplasms | 3 | 2010 | 324 | 0.220 |
Why?
|
Congenital Abnormalities | 2 | 1997 | 707 | 0.210 |
Why?
|
Pathology, Surgical | 1 | 2003 | 155 | 0.210 |
Why?
|
Papillomaviridae | 7 | 2017 | 1119 | 0.210 |
Why?
|
Metaplasia | 4 | 2008 | 313 | 0.200 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2004 | 3920 | 0.200 |
Why?
|
Estrogens, Non-Steroidal | 1 | 2001 | 54 | 0.200 |
Why?
|
Observer Variation | 7 | 2019 | 2593 | 0.200 |
Why?
|
Receptors, Estrogen | 6 | 2023 | 2187 | 0.200 |
Why?
|
Embryonic and Fetal Development | 2 | 2002 | 438 | 0.200 |
Why?
|
Uterine Cervical Dysplasia | 3 | 2017 | 387 | 0.190 |
Why?
|
RNA | 6 | 2004 | 2749 | 0.190 |
Why?
|
Estrogens | 3 | 2006 | 1566 | 0.190 |
Why?
|
Isoflavones | 1 | 2001 | 139 | 0.190 |
Why?
|
Ovarian Neoplasms | 6 | 2020 | 4838 | 0.190 |
Why?
|
Gene Expression Profiling | 7 | 2008 | 9438 | 0.190 |
Why?
|
Smooth Muscle Tumor | 2 | 2015 | 67 | 0.180 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2018 | 8428 | 0.180 |
Why?
|
Mutation | 18 | 2014 | 29786 | 0.180 |
Why?
|
Premenopause | 3 | 2009 | 1033 | 0.180 |
Why?
|
Testis | 5 | 1993 | 803 | 0.170 |
Why?
|
Cell Separation | 2 | 2016 | 1751 | 0.170 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2005 | 719 | 0.170 |
Why?
|
Tumor Virus Infections | 5 | 2003 | 452 | 0.170 |
Why?
|
Genes, ras | 2 | 1999 | 690 | 0.170 |
Why?
|
Platinum | 1 | 2020 | 233 | 0.170 |
Why?
|
Stromal Cells | 6 | 2007 | 1355 | 0.170 |
Why?
|
Ki-67 Antigen | 4 | 2017 | 644 | 0.160 |
Why?
|
Gene Expression Regulation | 7 | 2004 | 12072 | 0.160 |
Why?
|
Systems Theory | 1 | 2018 | 60 | 0.160 |
Why?
|
Cell Differentiation | 4 | 2013 | 11483 | 0.160 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2020 | 8949 | 0.160 |
Why?
|
Carcinosarcoma | 1 | 2019 | 108 | 0.160 |
Why?
|
Developmental Biology | 1 | 2018 | 76 | 0.150 |
Why?
|
Disease Progression | 9 | 2014 | 13284 | 0.150 |
Why?
|
Biophysics | 1 | 2018 | 383 | 0.150 |
Why?
|
DNA Mutational Analysis | 7 | 2009 | 4186 | 0.150 |
Why?
|
Lichen Sclerosus et Atrophicus | 1 | 1997 | 28 | 0.150 |
Why?
|
Knowledge | 1 | 2018 | 181 | 0.150 |
Why?
|
Sacrococcygeal Region | 1 | 1996 | 52 | 0.150 |
Why?
|
Alleles | 3 | 2000 | 6933 | 0.140 |
Why?
|
Genetic Heterogeneity | 1 | 2000 | 733 | 0.140 |
Why?
|
Hyperplasia | 6 | 2008 | 1185 | 0.140 |
Why?
|
Cryopreservation | 2 | 2016 | 670 | 0.140 |
Why?
|
DNA, Satellite | 1 | 1996 | 69 | 0.140 |
Why?
|
Adult | 31 | 2023 | 214055 | 0.140 |
Why?
|
Graphite | 1 | 2016 | 66 | 0.140 |
Why?
|
Middle Aged | 34 | 2020 | 213383 | 0.140 |
Why?
|
Nanotubes, Carbon | 1 | 2016 | 73 | 0.140 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 1999 | 506 | 0.130 |
Why?
|
Receptors, Androgen | 4 | 1997 | 1058 | 0.130 |
Why?
|
Workflow | 1 | 2020 | 847 | 0.130 |
Why?
|
Predictive Value of Tests | 7 | 2020 | 15076 | 0.130 |
Why?
|
Superoxides | 1 | 2016 | 387 | 0.130 |
Why?
|
Y Chromosome | 2 | 1993 | 206 | 0.130 |
Why?
|
Ovary | 3 | 1993 | 981 | 0.130 |
Why?
|
alpha-Thalassemia | 1 | 1994 | 46 | 0.130 |
Why?
|
Sex Chromosomes | 2 | 1993 | 105 | 0.120 |
Why?
|
Uterine Cervical Neoplasms | 6 | 2017 | 2020 | 0.120 |
Why?
|
Neoplasms | 3 | 2018 | 21683 | 0.120 |
Why?
|
Models, Biological | 3 | 2018 | 9583 | 0.120 |
Why?
|
Research Report | 1 | 2017 | 355 | 0.120 |
Why?
|
Progesterone Congeners | 1 | 2013 | 42 | 0.110 |
Why?
|
Retroperitoneal Neoplasms | 1 | 1996 | 340 | 0.110 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1995 | 798 | 0.110 |
Why?
|
Base Sequence | 12 | 1998 | 12797 | 0.110 |
Why?
|
Insemination, Artificial, Homologous | 1 | 1992 | 18 | 0.110 |
Why?
|
Sex Ratio | 1 | 1993 | 110 | 0.110 |
Why?
|
Neoplasm Invasiveness | 6 | 2008 | 3616 | 0.110 |
Why?
|
Germ-Line Mutation | 1 | 2000 | 1788 | 0.100 |
Why?
|
Trophoblasts | 1 | 1993 | 215 | 0.100 |
Why?
|
Insulin-Like Growth Factor II | 1 | 1993 | 271 | 0.100 |
Why?
|
DNA | 9 | 2014 | 7301 | 0.100 |
Why?
|
Cloning, Molecular | 3 | 1996 | 4320 | 0.100 |
Why?
|
DNA Primers | 5 | 2000 | 2892 | 0.100 |
Why?
|
Proto-Oncogenes | 2 | 1994 | 321 | 0.100 |
Why?
|
Molecular Sequence Data | 11 | 2000 | 18111 | 0.100 |
Why?
|
Cytodiagnosis | 1 | 2014 | 435 | 0.100 |
Why?
|
Papillomavirus Infections | 4 | 2017 | 1587 | 0.100 |
Why?
|
Allelic Imbalance | 2 | 2007 | 77 | 0.090 |
Why?
|
Chromosomes, Human | 2 | 1999 | 457 | 0.090 |
Why?
|
Necrosis | 1 | 2015 | 1643 | 0.090 |
Why?
|
Semen | 1 | 1992 | 316 | 0.090 |
Why?
|
Embryo, Mammalian | 2 | 2003 | 1701 | 0.090 |
Why?
|
Diagnosis, Differential | 5 | 2019 | 12959 | 0.090 |
Why?
|
Reproducibility of Results | 7 | 2017 | 19905 | 0.090 |
Why?
|
Carcinoma, Squamous Cell | 4 | 1999 | 4034 | 0.090 |
Why?
|
Models, Statistical | 2 | 2020 | 5102 | 0.090 |
Why?
|
Infertility, Male | 1 | 1992 | 409 | 0.080 |
Why?
|
Aged, 80 and over | 10 | 2014 | 57776 | 0.080 |
Why?
|
Schools | 3 | 1986 | 1433 | 0.080 |
Why?
|
Phenotype | 3 | 2018 | 16365 | 0.080 |
Why?
|
Aged | 19 | 2019 | 163280 | 0.080 |
Why?
|
Pathology, Clinical | 1 | 2012 | 368 | 0.080 |
Why?
|
Aneuploidy | 1 | 1991 | 530 | 0.080 |
Why?
|
Breast Neoplasms | 9 | 2007 | 20822 | 0.080 |
Why?
|
Health Education, Dental | 2 | 1978 | 26 | 0.080 |
Why?
|
Vulva | 2 | 1998 | 87 | 0.070 |
Why?
|
DNA Methylation | 3 | 1999 | 4286 | 0.070 |
Why?
|
Oocytes | 2 | 1993 | 1187 | 0.070 |
Why?
|
Genes, p53 | 2 | 2007 | 755 | 0.070 |
Why?
|
Homeostasis | 1 | 2018 | 3340 | 0.070 |
Why?
|
Soft Tissue Neoplasms | 1 | 1996 | 1363 | 0.070 |
Why?
|
Gene Deletion | 1 | 1994 | 2751 | 0.070 |
Why?
|
Stem Cells | 2 | 1997 | 3567 | 0.070 |
Why?
|
Reactive Oxygen Species | 1 | 2014 | 2077 | 0.070 |
Why?
|
Risk Factors | 8 | 2018 | 72290 | 0.070 |
Why?
|
Bleomycin | 1 | 1987 | 512 | 0.070 |
Why?
|
Genomic Instability | 2 | 2007 | 695 | 0.070 |
Why?
|
Meiosis | 1 | 1988 | 339 | 0.070 |
Why?
|
Genes, BRCA2 | 2 | 2006 | 618 | 0.070 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2009 | 604 | 0.060 |
Why?
|
Genes, BRCA1 | 2 | 2006 | 781 | 0.060 |
Why?
|
Oligospermia | 2 | 1997 | 59 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4042 | 0.060 |
Why?
|
Case-Control Studies | 4 | 2011 | 21746 | 0.060 |
Why?
|
Embryo, Nonmammalian | 1 | 1988 | 895 | 0.060 |
Why?
|
Gene Expression | 4 | 2001 | 7799 | 0.060 |
Why?
|
Single-Blind Method | 1 | 2008 | 1590 | 0.060 |
Why?
|
RNA, Messenger | 5 | 2000 | 13033 | 0.060 |
Why?
|
Turkey | 2 | 2017 | 237 | 0.060 |
Why?
|
Solutions | 1 | 2004 | 426 | 0.060 |
Why?
|
Insulin Resistance | 1 | 2018 | 3864 | 0.060 |
Why?
|
Nucleic Acid Hybridization | 5 | 1990 | 1375 | 0.060 |
Why?
|
Cell Proliferation | 3 | 2010 | 10481 | 0.060 |
Why?
|
Embryo Disposition | 1 | 2003 | 14 | 0.060 |
Why?
|
Preservation, Biological | 1 | 2003 | 25 | 0.060 |
Why?
|
Semen Preservation | 1 | 2003 | 35 | 0.060 |
Why?
|
Genes, Homeobox | 2 | 1998 | 286 | 0.060 |
Why?
|
Sperm Motility | 2 | 2016 | 253 | 0.060 |
Why?
|
Organ Specificity | 2 | 2001 | 2008 | 0.060 |
Why?
|
Terminology as Topic | 3 | 2012 | 1547 | 0.060 |
Why?
|
Mitosis | 1 | 2008 | 1208 | 0.060 |
Why?
|
Nuclear Proteins | 3 | 2014 | 5853 | 0.060 |
Why?
|
Lymphatic Metastasis | 2 | 2007 | 2924 | 0.050 |
Why?
|
Pulmonary Fibrosis | 1 | 1987 | 530 | 0.050 |
Why?
|
Genes | 1 | 1987 | 1893 | 0.050 |
Why?
|
Phosphoproteins | 2 | 2002 | 2440 | 0.050 |
Why?
|
Urogenital System | 1 | 2002 | 86 | 0.050 |
Why?
|
RNA Stability | 1 | 2004 | 321 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 2 | 2001 | 4554 | 0.050 |
Why?
|
Animals | 14 | 2018 | 168757 | 0.050 |
Why?
|
World Health Organization | 2 | 2005 | 1318 | 0.050 |
Why?
|
Prognosis | 7 | 2020 | 29063 | 0.050 |
Why?
|
Trans-Activators | 2 | 2002 | 2924 | 0.050 |
Why?
|
Chromosome Mapping | 2 | 2004 | 4740 | 0.050 |
Why?
|
Phytoestrogens | 1 | 2001 | 61 | 0.050 |
Why?
|
Body Mass Index | 3 | 2018 | 12720 | 0.050 |
Why?
|
Quality Indicators, Health Care | 1 | 2012 | 1831 | 0.050 |
Why?
|
Plants, Medicinal | 1 | 2001 | 167 | 0.050 |
Why?
|
Plant Preparations | 1 | 2001 | 94 | 0.050 |
Why?
|
Health Education | 2 | 1986 | 1056 | 0.050 |
Why?
|
Chromosome Aberrations | 1 | 1987 | 1813 | 0.050 |
Why?
|
Transcription, Genetic | 6 | 1993 | 7722 | 0.050 |
Why?
|
Sensitivity and Specificity | 6 | 2014 | 14722 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2019 | 63114 | 0.050 |
Why?
|
Self Administration | 1 | 2001 | 385 | 0.050 |
Why?
|
Genetic Markers | 3 | 1999 | 2634 | 0.050 |
Why?
|
Curettage | 1 | 2000 | 73 | 0.050 |
Why?
|
Biometry | 1 | 2003 | 558 | 0.050 |
Why?
|
Plants | 1 | 2001 | 316 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2016 | 10943 | 0.050 |
Why?
|
Cohort Studies | 2 | 2020 | 40561 | 0.040 |
Why?
|
Risk | 2 | 2009 | 9687 | 0.040 |
Why?
|
Transplantation, Isogeneic | 1 | 1980 | 257 | 0.040 |
Why?
|
Pregnancy | 7 | 2023 | 29144 | 0.040 |
Why?
|
Adnexa Uteri | 1 | 2019 | 45 | 0.040 |
Why?
|
Neoplastic Stem Cells | 1 | 1987 | 1376 | 0.040 |
Why?
|
Genome, Human | 3 | 2006 | 4420 | 0.040 |
Why?
|
Cell Lineage | 2 | 2000 | 2504 | 0.040 |
Why?
|
Response Elements | 1 | 2001 | 312 | 0.040 |
Why?
|
Teaching | 2 | 1978 | 1174 | 0.040 |
Why?
|
Histocytochemistry | 1 | 2000 | 719 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2023 | 890 | 0.040 |
Why?
|
G2 Phase | 1 | 1998 | 139 | 0.040 |
Why?
|
Genes, cdc | 1 | 1998 | 116 | 0.040 |
Why?
|
Transcription Factors | 3 | 2014 | 12208 | 0.040 |
Why?
|
Administration, Oral | 1 | 2006 | 3913 | 0.040 |
Why?
|
Mutation, Missense | 1 | 2007 | 2564 | 0.040 |
Why?
|
Online Systems | 1 | 2019 | 184 | 0.040 |
Why?
|
Omentum | 1 | 2019 | 170 | 0.040 |
Why?
|
Parthenogenesis | 1 | 1997 | 31 | 0.040 |
Why?
|
Menopause | 1 | 2006 | 1626 | 0.040 |
Why?
|
Estradiol | 2 | 2002 | 2020 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2019 | 6895 | 0.040 |
Why?
|
Receptors, Adiponectin | 1 | 2018 | 81 | 0.040 |
Why?
|
Genital Neoplasms, Female | 1 | 2003 | 523 | 0.040 |
Why?
|
Choriocarcinoma | 1 | 1997 | 126 | 0.040 |
Why?
|
Polymorphism, Restriction Fragment Length | 3 | 1994 | 768 | 0.040 |
Why?
|
Blotting, Northern | 3 | 1993 | 1581 | 0.040 |
Why?
|
Neoplasm Proteins | 3 | 2010 | 3703 | 0.040 |
Why?
|
Beckwith-Wiedemann Syndrome | 1 | 1997 | 43 | 0.040 |
Why?
|
Spermatogonia | 1 | 1997 | 29 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2001 | 4851 | 0.040 |
Why?
|
Leiomyomatosis | 1 | 1997 | 70 | 0.040 |
Why?
|
Thyroid Neoplasms | 2 | 2000 | 2282 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 2005 | 3798 | 0.040 |
Why?
|
Teratogens | 1 | 1997 | 112 | 0.040 |
Why?
|
Prader-Willi Syndrome | 1 | 1997 | 79 | 0.030 |
Why?
|
Mucins | 1 | 1999 | 564 | 0.030 |
Why?
|
Thyroid Gland | 2 | 2000 | 1173 | 0.030 |
Why?
|
Receptors, Leptin | 1 | 2018 | 360 | 0.030 |
Why?
|
Globins | 2 | 1994 | 415 | 0.030 |
Why?
|
Colposcopy | 1 | 2017 | 144 | 0.030 |
Why?
|
Embalming | 1 | 1975 | 13 | 0.030 |
Why?
|
Young Adult | 3 | 2013 | 56430 | 0.030 |
Why?
|
Estrogen Replacement Therapy | 1 | 2002 | 1203 | 0.030 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2000 | 484 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2005 | 2455 | 0.030 |
Why?
|
Deoxyguanine Nucleotides | 1 | 1995 | 21 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2004 | 6365 | 0.030 |
Why?
|
Cytoplasm | 1 | 2000 | 1539 | 0.030 |
Why?
|
Cluster Analysis | 3 | 2012 | 2715 | 0.030 |
Why?
|
Tumor Stem Cell Assay | 1 | 1995 | 118 | 0.030 |
Why?
|
Nucleic Acid Denaturation | 1 | 1995 | 111 | 0.030 |
Why?
|
Signal Transduction | 1 | 2018 | 23403 | 0.030 |
Why?
|
Sperm Injections, Intracytoplasmic | 1 | 2016 | 160 | 0.030 |
Why?
|
Base Composition | 1 | 1995 | 293 | 0.030 |
Why?
|
Sex Chromosome Aberrations | 1 | 1995 | 114 | 0.030 |
Why?
|
DNA, Mitochondrial | 1 | 2000 | 817 | 0.030 |
Why?
|
Mosaicism | 1 | 1997 | 441 | 0.030 |
Why?
|
Oxides | 1 | 2016 | 405 | 0.030 |
Why?
|
Carcinoma, Papillary | 1 | 2000 | 783 | 0.030 |
Why?
|
Islets of Langerhans Transplantation | 1 | 1980 | 745 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2002 | 7880 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2001 | 1783 | 0.030 |
Why?
|
Vulvar Diseases | 1 | 1994 | 61 | 0.030 |
Why?
|
Obesity | 1 | 2017 | 12745 | 0.030 |
Why?
|
Retrospective Studies | 8 | 2019 | 77449 | 0.030 |
Why?
|
Blotting, Southern | 1 | 1994 | 803 | 0.030 |
Why?
|
Decision Making | 1 | 2008 | 3887 | 0.030 |
Why?
|
Wilms Tumor | 1 | 1997 | 373 | 0.030 |
Why?
|
DNA, Viral | 3 | 1998 | 2225 | 0.030 |
Why?
|
Tissue Donors | 1 | 2003 | 2240 | 0.030 |
Why?
|
Genes, mos | 1 | 1993 | 3 | 0.030 |
Why?
|
Genetic Variation | 3 | 2004 | 6544 | 0.030 |
Why?
|
Individuality | 1 | 1995 | 307 | 0.030 |
Why?
|
Vaginal Smears | 1 | 2017 | 511 | 0.030 |
Why?
|
Receptor, Insulin | 1 | 2018 | 846 | 0.030 |
Why?
|
DNA Fragmentation | 1 | 2014 | 242 | 0.030 |
Why?
|
Ploidies | 1 | 1994 | 281 | 0.030 |
Why?
|
Male | 20 | 2016 | 350118 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 705 | 0.030 |
Why?
|
Spermatocytes | 1 | 1993 | 42 | 0.030 |
Why?
|
Time Factors | 3 | 2010 | 40075 | 0.030 |
Why?
|
Genes, abl | 1 | 1993 | 72 | 0.030 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 1980 | 1116 | 0.030 |
Why?
|
Gene Amplification | 2 | 1994 | 1063 | 0.030 |
Why?
|
Fertilization in Vitro | 2 | 2016 | 1284 | 0.030 |
Why?
|
Phylogeny | 1 | 2000 | 2803 | 0.030 |
Why?
|
Cytological Techniques | 1 | 2014 | 219 | 0.030 |
Why?
|
Gynecology | 1 | 2019 | 513 | 0.030 |
Why?
|
Genes, myc | 1 | 1994 | 399 | 0.030 |
Why?
|
In Situ Hybridization | 2 | 1993 | 1950 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 4751 | 0.030 |
Why?
|
DNA Probes | 1 | 1993 | 560 | 0.030 |
Why?
|
Ejaculation | 1 | 1992 | 58 | 0.030 |
Why?
|
Abortion, Spontaneous | 1 | 1997 | 544 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2001 | 2503 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 3 | 1991 | 1085 | 0.030 |
Why?
|
DNA-Binding Proteins | 4 | 2014 | 9648 | 0.030 |
Why?
|
Cell Division | 1 | 1999 | 4568 | 0.030 |
Why?
|
Tumor Cells, Cultured | 5 | 2001 | 6314 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 7913 | 0.030 |
Why?
|
Nucleic Acid Heteroduplexes | 1 | 1991 | 47 | 0.030 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 1999 | 1101 | 0.030 |
Why?
|
Chorionic Gonadotropin | 1 | 1994 | 477 | 0.030 |
Why?
|
Adiponectin | 1 | 2018 | 1100 | 0.030 |
Why?
|
Cervix Uteri | 1 | 1995 | 590 | 0.030 |
Why?
|
Sperm Count | 1 | 1992 | 216 | 0.030 |
Why?
|
Mice | 12 | 2002 | 81183 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 1980 | 2382 | 0.020 |
Why?
|
Nucleic Acid Conformation | 1 | 1995 | 913 | 0.020 |
Why?
|
Biological Specimen Banks | 1 | 2016 | 711 | 0.020 |
Why?
|
Peritoneal Neoplasms | 1 | 1997 | 665 | 0.020 |
Why?
|
Canada | 3 | 1986 | 2065 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2000 | 2969 | 0.020 |
Why?
|
Reference Values | 2 | 2001 | 4982 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2009 | 25043 | 0.020 |
Why?
|
Homozygote | 1 | 1995 | 1785 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2016 | 2187 | 0.020 |
Why?
|
Genotype | 2 | 2007 | 12951 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2017 | 1405 | 0.020 |
Why?
|
Sequence Deletion | 1 | 1994 | 1526 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 1995 | 1060 | 0.020 |
Why?
|
Genes, p16 | 1 | 2010 | 157 | 0.020 |
Why?
|
Head | 1 | 1975 | 880 | 0.020 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2014 | 482 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2016 | 828 | 0.020 |
Why?
|
DNA, Single-Stranded | 1 | 1991 | 354 | 0.020 |
Why?
|
Cells, Cultured | 3 | 2016 | 19229 | 0.020 |
Why?
|
Zinc Fingers | 1 | 1991 | 585 | 0.020 |
Why?
|
Microdissection | 1 | 2009 | 152 | 0.020 |
Why?
|
Keratins | 2 | 2001 | 515 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2001 | 3297 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-mos | 1 | 1988 | 17 | 0.020 |
Why?
|
Epithelium | 2 | 2007 | 1679 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7279 | 0.020 |
Why?
|
Bucladesine | 1 | 1988 | 121 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6538 | 0.020 |
Why?
|
Research | 1 | 1997 | 1999 | 0.020 |
Why?
|
Databases, Factual | 1 | 2003 | 7729 | 0.020 |
Why?
|
Facial Bones | 1 | 1989 | 201 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2728 | 0.020 |
Why?
|
Cell Line | 3 | 1994 | 15997 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 1997 | 1903 | 0.020 |
Why?
|
Receptor Cross-Talk | 1 | 2007 | 119 | 0.020 |
Why?
|
Consensus | 1 | 2017 | 2959 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2016 | 2132 | 0.020 |
Why?
|
Antigens, CD | 1 | 2018 | 4026 | 0.020 |
Why?
|
Tonsillar Neoplasms | 1 | 1987 | 51 | 0.020 |
Why?
|
Infant, Newborn | 2 | 1997 | 25625 | 0.020 |
Why?
|
Pterygoid Muscles | 1 | 1986 | 8 | 0.020 |
Why?
|
Societies, Medical | 1 | 2019 | 3743 | 0.020 |
Why?
|
Masseter Muscle | 1 | 1986 | 36 | 0.020 |
Why?
|
Masticatory Muscles | 1 | 1986 | 29 | 0.020 |
Why?
|
Mandibular Nerve | 1 | 1986 | 58 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5882 | 0.020 |
Why?
|
School Nursing | 1 | 1986 | 31 | 0.020 |
Why?
|
DNA Polymerase III | 1 | 2006 | 55 | 0.020 |
Why?
|
Megakaryocytes | 1 | 1990 | 545 | 0.020 |
Why?
|
Hypesthesia | 1 | 1986 | 109 | 0.020 |
Why?
|
Workplace | 1 | 2012 | 836 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 1991 | 987 | 0.020 |
Why?
|
Prospective Studies | 2 | 2000 | 53288 | 0.020 |
Why?
|
Genes, Regulator | 1 | 1986 | 378 | 0.020 |
Why?
|
Breast | 2 | 2007 | 1969 | 0.020 |
Why?
|
Skull | 1 | 1989 | 813 | 0.020 |
Why?
|
Body Weights and Measures | 1 | 2005 | 211 | 0.020 |
Why?
|
Fibroma | 1 | 1986 | 212 | 0.020 |
Why?
|
Chromosome Banding | 1 | 2004 | 278 | 0.020 |
Why?
|
Posthumous Conception | 1 | 2003 | 11 | 0.010 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2004 | 326 | 0.010 |
Why?
|
Lung Neoplasms | 2 | 2005 | 13102 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1994 | 4420 | 0.010 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2006 | 780 | 0.010 |
Why?
|
Genetic Diseases, Inborn | 1 | 2007 | 587 | 0.010 |
Why?
|
Clitoris | 1 | 2002 | 33 | 0.010 |
Why?
|
Tissue Banks | 1 | 2003 | 184 | 0.010 |
Why?
|
HMGA2 Protein | 1 | 2003 | 123 | 0.010 |
Why?
|
Mast Cells | 1 | 1990 | 1544 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1987 | 2327 | 0.010 |
Why?
|
Genes, Neoplasm | 1 | 2004 | 376 | 0.010 |
Why?
|
School Health Services | 1 | 1986 | 375 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2005 | 13695 | 0.010 |
Why?
|
Abnormalities, Multiple | 1 | 1989 | 1416 | 0.010 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2004 | 658 | 0.010 |
Why?
|
Marital Status | 1 | 2003 | 437 | 0.010 |
Why?
|
Aspartate Carbamoyltransferase | 1 | 1981 | 22 | 0.010 |
Why?
|
RNA, Neoplasm | 1 | 2004 | 769 | 0.010 |
Why?
|
Collodion | 1 | 2001 | 34 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2012 | 2266 | 0.010 |
Why?
|
Molecular Biology | 1 | 2005 | 596 | 0.010 |
Why?
|
Keratin-14 | 1 | 2001 | 57 | 0.010 |
Why?
|
Smoking | 1 | 1978 | 8987 | 0.010 |
Why?
|
Genetic Testing | 1 | 1994 | 3444 | 0.010 |
Why?
|
NADH Dehydrogenase | 1 | 2000 | 41 | 0.010 |
Why?
|
Erythrocytes | 1 | 1990 | 2455 | 0.010 |
Why?
|
Calmodulin | 1 | 2001 | 209 | 0.010 |
Why?
|
Biochemistry | 1 | 2001 | 113 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 1989 | 2421 | 0.010 |
Why?
|
Anal Canal | 1 | 2002 | 376 | 0.010 |
Why?
|
DNA Replication | 1 | 2006 | 1399 | 0.010 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 1999 | 287 | 0.010 |
Why?
|
Polyomaviridae | 1 | 1998 | 9 | 0.010 |
Why?
|
Death | 1 | 2003 | 678 | 0.010 |
Why?
|
Histones | 1 | 2009 | 2599 | 0.010 |
Why?
|
Serpins | 1 | 2000 | 247 | 0.010 |
Why?
|
Pedigree | 1 | 2006 | 4644 | 0.010 |
Why?
|
Cricetulus | 1 | 1980 | 816 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2009 | 3462 | 0.010 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 1997 | 68 | 0.010 |
Why?
|
Antibody Specificity | 1 | 1999 | 1095 | 0.010 |
Why?
|
Boston | 1 | 2010 | 9313 | 0.010 |
Why?
|
Ontario | 1 | 1978 | 383 | 0.010 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2000 | 434 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2002 | 2726 | 0.010 |
Why?
|
Hormones | 1 | 2001 | 889 | 0.010 |
Why?
|
Kallmann Syndrome | 1 | 1997 | 140 | 0.010 |
Why?
|
Tamoxifen | 1 | 2001 | 981 | 0.010 |
Why?
|
Museums | 1 | 1975 | 19 | 0.010 |
Why?
|
Ecuador | 1 | 1975 | 55 | 0.010 |
Why?
|
Cricetinae | 1 | 1980 | 2472 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2001 | 1880 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 1981 | 1276 | 0.010 |
Why?
|
Anthropology, Cultural | 1 | 1975 | 99 | 0.010 |
Why?
|
Karyotyping | 1 | 1997 | 1243 | 0.010 |
Why?
|
Fraud | 1 | 1975 | 67 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 1994 | 18029 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2006 | 4803 | 0.010 |
Why?
|
Mucous Membrane | 1 | 1998 | 673 | 0.010 |
Why?
|
Adolescent | 3 | 2010 | 85781 | 0.010 |
Why?
|
Promoter Regions, Genetic | 2 | 1999 | 5867 | 0.010 |
Why?
|
Antisense Elements (Genetics) | 1 | 1993 | 37 | 0.010 |
Why?
|
Motivation | 1 | 2003 | 1971 | 0.010 |
Why?
|
Multigene Family | 1 | 1997 | 1102 | 0.010 |
Why?
|
Islets of Langerhans | 1 | 1980 | 1352 | 0.010 |
Why?
|
Poly A | 1 | 1993 | 185 | 0.010 |
Why?
|
Clone Cells | 1 | 1997 | 1692 | 0.010 |
Why?
|
Attitude | 1 | 1978 | 776 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39050 | 0.010 |
Why?
|
History, 19th Century | 1 | 1975 | 720 | 0.010 |
Why?
|
Gene Silencing | 1 | 1999 | 1538 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1993 | 427 | 0.010 |
Why?
|
Chromosome Deletion | 1 | 1997 | 1401 | 0.010 |
Why?
|
Isotope Labeling | 1 | 1994 | 406 | 0.010 |
Why?
|
Behavior Therapy | 1 | 1978 | 865 | 0.010 |
Why?
|
Head and Neck Neoplasms | 1 | 1986 | 2734 | 0.010 |
Why?
|
Gene Frequency | 1 | 1999 | 3588 | 0.010 |
Why?
|
Blotting, Western | 1 | 1999 | 5179 | 0.010 |
Why?
|
United States | 2 | 2012 | 69872 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1994 | 1799 | 0.010 |
Why?
|
Sulfonamides | 1 | 2001 | 1938 | 0.010 |
Why?
|
RNA, Antisense | 1 | 1991 | 138 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1991 | 878 | 0.010 |
Why?
|
Heterozygote | 1 | 1997 | 2804 | 0.010 |
Why?
|
RNA Probes | 1 | 1990 | 113 | 0.010 |
Why?
|
Erythroid-Specific DNA-Binding Factors | 1 | 1990 | 198 | 0.010 |
Why?
|
Aging | 2 | 2003 | 8664 | 0.010 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 1990 | 189 | 0.010 |
Why?
|
Internet | 1 | 2001 | 3064 | 0.010 |
Why?
|
Adenoma | 1 | 2000 | 2174 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 1999 | 2916 | 0.010 |
Why?
|
Glucose | 1 | 1980 | 4397 | 0.000 |
Why?
|
History, 20th Century | 1 | 1975 | 2740 | 0.000 |
Why?
|
Mice, Knockout | 1 | 2002 | 14557 | 0.000 |
Why?
|
Neural Crest | 1 | 1989 | 275 | 0.000 |
Why?
|
Polymorphism, Genetic | 1 | 1997 | 4328 | 0.000 |
Why?
|
Carrier Proteins | 1 | 1999 | 5021 | 0.000 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2001 | 5172 | 0.000 |
Why?
|
Cranial Nerve Diseases | 1 | 1986 | 112 | 0.000 |
Why?
|
Genetic Linkage | 1 | 1991 | 2421 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 2000 | 11031 | 0.000 |
Why?
|
Insulin | 1 | 1980 | 6580 | 0.000 |
Why?
|
Proteins | 1 | 2000 | 6103 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1999 | 9274 | 0.000 |
Why?
|
Bone Marrow Cells | 1 | 1990 | 2513 | 0.000 |
Why?
|
Placenta | 1 | 1991 | 1698 | 0.000 |
Why?
|
Actins | 1 | 1989 | 2121 | 0.000 |
Why?
|
Orotic Acid | 1 | 1981 | 23 | 0.000 |
Why?
|
Phosphonoacetic Acid | 1 | 1981 | 55 | 0.000 |
Why?
|
Ribose | 1 | 1981 | 68 | 0.000 |
Why?
|
Ribonucleosides | 1 | 1981 | 82 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1991 | 13815 | 0.000 |
Why?
|
Aspartic Acid | 1 | 1981 | 576 | 0.000 |
Why?
|
Amides | 1 | 1981 | 459 | 0.000 |
Why?
|
Child | 1 | 1986 | 77709 | 0.000 |
Why?
|
Hematopoietic Stem Cells | 1 | 1990 | 3386 | 0.000 |
Why?
|
Mice, Transgenic | 1 | 1989 | 9734 | 0.000 |
Why?
|
Drug Resistance | 1 | 1981 | 1609 | 0.000 |
Why?
|
Pyrazoles | 1 | 1981 | 1972 | 0.000 |
Why?
|
Pyrimidines | 1 | 1981 | 2942 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1986 | 20129 | 0.000 |
Why?
|